The Masters Portfolio: 5 Stocks to Buy

These companies don't just have the cash to sponsor the PGA's best -- they're also excellent investments

      View All  
The Masters Portfolio: 5 Stocks to Buy

The Masters Portfolio: Phil Mickelson, 12/1

Amgen 185 The Masters Portfolio: 5 Stocks to BuyMickelson Sponsor Stock: Enbrel/Amgen (AMGN)

Is a fourth green jacket in the works for Phil Mickelson this weekend?

With 24 first-timers in the field at the Masters, experience is going to be in shorter supply at this year’s tournament, which plays right into the lefty’s very capable hands. Unfortunately, Mickelson is having a mediocre season by his standards, garnering no top-10s in the nine tournaments he has played so far in 2014 — and he has even missed a cut.

However, if there’s anyone that can pull it together for one tournament, it would have to be Phil.

Right there on Enbrel’s homepage is Phil holding a driver. You’ve likely seen the ads where he admits to having rheumatoid arthritis, then is running around a field playing with a bunch of kids implying that the drug works for him and millions of others. This isn’t some energy drink or car brand where you question whether he actually uses it, but something necessary to keep playing golf.

For this reason, I’m putting Amgen (AMGN) — the maker of Enbrel — on the list.


Article printed from InvestorPlace Media, http://investorplace.com/2014/04/the-masters-stocks-to-buy/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.